- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Julia Warren McDonald, MD
- Resident, PGY-3
Julia W. McDonald, MD is a pediatric resident and part of the Pediatric Advocacy Leadership and Service (PALS) track at UPMC Children’s Hospital of Pittsburgh. Julia received her Bachelor of Arts degree from Providence College and her Doctor of Medicine degree from Dartmouth’s Geisel School of Medicine. She worked for three years between undergraduate and medical school as a research assistant completing Alzheimer’s Disease clinical trials at Yale University. She started her residency training here in June 2021.
Julia is interested in improving the social and environmental factors that influence the health of a pediatric population and is in the process of serving on a non-profit board in Pittsburgh that focuses on maintaining and sustaining affordable housing. She has been a member for physicians for human rights and previously worked to create an asylum clinic for asylum-seekers where they can receive forensic physical exam evaluations to substantiate their application for asylum in the United States.
Fellow Biographical Details
- Hometown
-
Weston, Connecticut
- College or Medical School
-
Dartmouth Geisel School of Medicine
Professional and Scientific Society Memberships
- Medical Students for Choice
- Allies of Women in Medicine
- Physicians for Human Rights
Education & Training
- BA, Psychology, magna cum laude, Providence College, 2014
- MD, Dartmouth Geisel School of Medicine, 2021
Selected Publications
Mecca, AP, Rogers, K, Jacobs, Z, McDonald, JW, Michalak, HR et al. Effect of Age on Brain Metabotropic Glutamate Receptor Subtype 5 Measured with [18F]FPEB PET. NeuroImage. Accepted 25 May 2021. Available online 27 May 2021.
Chen M, Mecca AP, Naganawa M, Gallezot J, Toyonaga T, Mondal J, Finnema S, Lin S, O’Dell R, McDonald JW, Michalak, HR et al. Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study. Journal of Cerebral Blood Flow & Metabolism. 2021, Mar; Pub Status: Accepted. PMID: 33757318.
Higgins TH, Pham M, McDonald JW, Neveu ML, Haslett, W, Erekson, E, Wilkinson-Ryan, I. The effect of state legislation on changing opioid prescribing practices following gynecologic surgery. Journal of Gynecological Surgery. 2020, Oct; Pub Status: Accepted
Mecca AP, McDonald JW, Michalak HR et al. PET imaging of mGluR5 in Alzheimer’s Disease. Alzheimers Res Ther. 2020;12(1):15. PMID: 31954399.
Kemp EC, Ebner MK, Ramanan S, Godek TA, Pugh EA, Bartlett HH, McDonald JW Et al. Statin Use and Risk of Cognitive Decline in ADNI Cohort. American Journal of Geriatric Psychiatry. 2020;28(5):507-517. PMID: 31806426.
Mecca AP, Michalak HR, McDonald JW Et al. Sleep Disturbance and Risk of Cognitive Decline in the ADNI Cohort. Dementia and Geriatric Cognitive Disorders. 2018;45:232-242. PMID: 29886490.
Chen MC, Mecca AP, Naganawa M, Finnema SJ, Toyonaga T, Lin S, Najafzadeh S, Ropchan J, Lu, Y, McDonald JW Et al. Assessing Synaptic Density in Alzheimer Disease with Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging. JAMA Neurol. 2018;75(10):1215-1224. PMID: 30014145.